AD Ormerod
Impact in
-
- Therapeutic Uses of Natural Elements
-
- Dermatology and Skin Diseases
Papers in
-
- Toxin Mechanisms and Immunotoxins 2
- Psoriasis: Treatment and Pathogenesis 2
-
- Dermatology and Skin Diseases 2
- Dermatological and COVID-19 studies 1
- Cutaneous lymphoproliferative disorders research 1
- Co-authors
- Natalie Reytan (1 shared paper)Phyllis I. Spuls (1 shared paper)Catherine Smith (2 shared papers)Alexander Nast (1 shared paper)Berthold Rzany (1 shared paper)A.J. Winfield (1 shared paper)Aroonsri Priprem (1 shared paper)Darren M. Ashcroft (1 shared paper)
- Journals
- Journal of Dermatological Treatment (2 papers)British Journal of Dermatology (1 paper)Journal of the European Academy of Dermatology and Venereology (1 paper)Journal of Inflammation (1 paper)Scottish Medical Journal (1 paper)
- Partner nations
- United KingdomGermanyNetherlands
In The Last Decade
AD Ormerod
7 papers receiving 44 citations
Peers
Comparison fields: 5 of 28
- Complementary and Manual Therapy 3
- Dermatology 12
- Pharmaceutical Science 5
- Immunology 16
- Complementary and alternative medicine 3
Countries citing papers authored by AD Ormerod
This map shows the geographic impact of AD Ormerod's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by AD Ormerod with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites AD Ormerod more than expected).
Fields of papers citing papers by AD Ormerod
This network shows the impact of papers produced by AD Ormerod. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by AD Ormerod. The network helps show where AD Ormerod may publish in the future.
Co-authors
The 19 scholars most cited alongside AD Ormerod, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 27 | |
| 2 | 2008 | 7 | |
| 3 | 1992 | 4 | |
| 4 | Pimecrolimus cream 1% once-daily maintenance therapy for the prevention of relapse in mild to moderate dermatitis in adults. | 2005 | 2 |
| 5 | 2015 | 2 | |
| 6 | Persistence with biologic therapies for the treatment of moderate to severe psoriasis: a prospective observational study from the British Association of Dermatologists Biologic Interventions Register (BADBIR). | 2014 | 2 |
| 7 | 1998 | 1 |
About AD Ormerod
AD Ormerod is a scholar working on Immunology, Dermatology, Rheumatology, Pathology and Forensic Medicine and Pediatrics, Perinatology and Child Health, having authored 7 papers that have together received 45 indexed citations. Recurring topics across this work include Toxin Mechanisms and Immunotoxins (2 papers), Urticaria and Related Conditions (2 papers), Psoriasis: Treatment and Pathogenesis (2 papers), Dermatology and Skin Diseases (2 papers), Dermatological and COVID-19 studies (1 paper), Cutaneous lymphoproliferative disorders research (1 paper), Pesticide Exposure and Toxicity (1 paper) and Cancer Immunotherapy and Biomarkers (1 paper). The work is most often cited by research in Complementary and Manual Therapy (3 citations), Dermatology (12 citations), Pharmaceutical Science (5 citations), Immunology (16 citations) and Complementary and alternative medicine (3 citations). AD Ormerod has collaborated with scholars based in United Kingdom, Germany and Netherlands. Frequent co-authors include Natalie Reytan, Phyllis I. Spuls, Catherine Smith, Alexander Nast, Berthold Rzany, A.J. Winfield, Aroonsri Priprem, Darren M. Ashcroft, Mark Lunt and Femke J. M. Muller. Their work appears in journals such as Journal of Dermatological Treatment, British Journal of Dermatology, Journal of the European Academy of Dermatology and Venereology, Journal of Inflammation and Scottish Medical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.